Past week
All results
- All results
- Verbatim
Rating
(943)
3 days ago · Amil é condenada a fornecer Kisqali® (Ribociclibe) e Seletiv® (Fulvestranto) após negativa de cobertura a paciente com câncer.
Rating
(943)
3 days ago · SulAmérica Saúde é condenada a reembolsar paciente por negativa de cobertura do medicamento Mabthera® (Rituximabe).
In order to show you the most relevant results, we have omitted some entries very similar to the 2 already displayed.
If you like, you can repeat the search with the omitted results included. |